Current Issue May 2012, Vol. 15, No. 3

Featured Article

PREFERENCE_BASED ASSESSMENT

Condition specific preference-based measures: benefit or burden?
The introduction of preference-based measures which are specific to a certain disease may have the merit of sensitivity to disease specific effects of interventions.

 

Issue Highlights

ECONOMIC EVALUATION
Simulated Value Based Insurance Design Applied to Statin Use by Medicare Beneficiaries with Diabetes
Reducing statin copayments for Medicare beneficiaries with diabetes resulted in modestly increased use, and reduced medical spending.

PATIENT REPORTED OUTCOMES
A Review of Patient-Reported Outcomes Labels in the US: 2006-2010
The FDA continues to approve PRO claims, with 24% of NMEs and BLAs being granted.

PREFERENCE-BASED ASSESSMENTS
Do general practitioners know patients' preferences? An empirical study on the agency relationship at an aggregate level using a discrete choice experiment
Our findings highlight the need for policy makers, even when absorbed with reducing cost, to design cost containment It is concluded that general practitioners (GPs) do not have a precise knowledge of patients’ preferences.

COMPARATIVE EFFECTIVENESS RESEARCH / HTA
Efficacy of Once-daily Indacaterol Relative to Alternative Bronchodilators in COPD: A Patient Level Mixed Treatment Comparison Indacaterol is expected to be comparable to formoterol, salmeterol and tiotropium, providing higher FEV1 than formoterol and salmeterol, and greater improvement in SGRQ total score than tiotropium.

HEALTH POLICY ANALYSIS
Decision making criteria among national policy makers in five countries: a discrete choice experiment eliciting relative preferences for equity and efficiency Policy-makers’ preferences across countries show explicit but varying tradeoffs of efficiency and equity that we expect to see in these diverse settings.

Additional articles can also be found in this issue of Value in Health in Methodology, Policy Perspectives, as well as a 'Reflections' piece by 2012 ISPOR Avedis Donabedian Lifetime Achievement in Outcomes Research Award recipient Sir Michael Rawlins, MD, FMedSci.

 

  • How Do Insured Perceive Their Financial Security in the Event of Illness?—A Panel Data Analysis for Germany
    23 April 2012

    Ansgar Lange, Anne Prenzler, Andy Zuchandke

  • Heterogeneous Effects of Health Insurance on Out-of-Pocket Expenditure on Medicines in Mexico
    16 April 2012

    Veronika J. Wirtz, Yared Santa-Ana-Tellez, Edson Servan-Mori, Leticia Avila-Burgos

  • View More Articles in Press...

Cover Image

About Value in Health

Value in Health contains original research articles for pharmacoeconomics, health economics, and outcomes research (clinical, economic, and patient-reported outcomes/preference-based research), as well as conceptual and health policy articles that provide valuable information for health care decision-makers as well as the research community. As the official journal of ISPOR, Value in Health provides a forum for researchers, as well as health care decision-makers to translate outcomes research into health care decisions.

Journal Ranking

2010 Impact Factor: 2.342
5 Year Impact Factor: 2.992
© 2011 Journal Citation Report®, Thomson Reuters

Ranking 16 out of 71 Health Care Sciences & Services

Paper of the Year Award

Nicola Cooper

Nicola J. Cooper, PhD, is the winner of the 2012 ISPOR Paper of the Year Award. Dr. Cooper is a Professor of Healthcare Evaluation Research at the University of Leicester, UK. Her research experience spans a range of academic disciplines including health economics, health services research and medical statistics, and most excitingly, the interface and integration of all three. Nicola joined the Biostatistics group at Leicester in 2000 and since then, her research has focused on the development and application of methods for evidence synthesis and economic decision modelling to inform health technology appraisals. This research has led to collaborations with renowned experts in the area both nationally and internationally, leading to numerous research grants and the development of specialist courses delivered worldwide. The paper, on which the 2012 ISPOR Award for Value in Health Paper of the Year was awarded, was funded by an MRC methodology grant and is an example of the collaborative research Nicola is currently undertaking.

Access this journal onSciVerse ScienceDirect
Print or Share This Page

Welcome From the Co-Editors-in-Chief

Co-Editors-in-Chief, Michael Drummond and C. Daniel Mullins introduce the new Value in Health website.

ISPOR Efforts in Communication

 

Intro to ISPOR Vision 2020 and Brazil Chapter

 

The ISPOR House Band, "The Monte Carlos", performing at the ISPOR 15th Annual International Meeting in Atlanta GA, USA, May 18, 2010.

 

Improving The Efficiency In Assessment Of Health Technology In Europe
ISPOR 13th Annual European Congress, Prague, Czech Republic - November 2010

Video--flashvideo1JVAL--http://podcasts.elsevierhealth.com/JVAL/Tape1Prague20102.flv--/webfiles/images/journals/JVAL/Tape1Prague20102.gif

Personalized Medicine: The Value of Targeted Therapy
ISPOR 15th International Meeting, Atlanta, GA, USA - May 2010

Video--flashvideo2JVAL--http://podcasts.elsevierhealth.com/JVAL/_Atlanta2010.flv--/webfiles/images/journals/JVAL/_Atlanta2010.gif

Health Care Reimbursement Systems in Europe: Learning from Each Other
ISPOR 12th Annual European Congress, Paris, France - October 2009

Video--flashvideo3JVAL--http://podcasts.elsevierhealth.com/JVAL/ISPOR.flv--/webfiles/images/journals/JVAL/ISPOR_video.gif

Value in Health Editorial Boards

The Value in Health Editorial Boards at the ISPOR 16th Annual International Meeting in Baltimore, MD, USA, May 2011.

Society Information

ISPOR

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a non-profit international organization promoting the science of pharmacoeconomics and health outcomes research (clinical, economic, and patient-reported outcomes). The ISPOR mission is to translate pharmacoeconomics and outcomes research into practice to ensure that society allocates scarce health care resources wisely, fairly, and efficiently.

Publishing Information

Elsevier

Value in Health is published by Elsevier for the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).